SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " atm " 2,171 found 🔀 AI-powered Shuffle
Germany’s Political Tailspin: Your Weekly SPIEGEL Recap
It might be tempting to dismiss the results of last Sunday’s state election in Saxony-Anhalt, in which the far-right Alternative for Germany (AfD) party raked in 43.8 percent of the vote, as a rather unimportant extremist blip in a state that hardly anyone can find on the map. And you wouldn’t necessarily be wrong to do so. The state’s population – around 2.1 million – is a mere 2.5 percent of the German total. And while the state capital of Magdeburg was once the political heart of the Holy Roman Empire back when Otto the Great used to hang out there (more than a millenium … no … milennium … nope … millennium ago), it is today something of a backwater, albeit one with a ginormous cathedral in its center. We wanted to briefly interrupt this week’s newsletter to extend a heartfelt thank you to all of our subscribers, both new and old. And to remind you all that a free subscription gets you access to this newsletter every Saturday. A paid subscription, by contrast, gets you one DER SPIEGEL article every weekday, delivered to your inbox. We strive to select pieces that both demonstrate what Europe’s leading newsmagazine has to offer and provide an international audience – namely, you – with an insight into how Germany and Europe view the world. If you haven’t already signed up for a paid subscription, please consider doing so if you can. Our Substack channel relies entirely on reader support and we are excited to continue offering you the best of DER SPIEGEL. Subscribe But even beyond the fact that a huge percentage of the voters in the state decided to place an X next to a party with an ideological lineage that runs rather directly back to the right-wing extremist soup out of which the Nazi Party was born, the results are a perfect example of a phenomenon that has been plaguing German elections in recent years: the lack of an obvious path to a majority. Call it the Balkanization of German politics. There are a number of developments driving the phenomenon, but for the purposes of this newsletter, here are two of the most salient: Persistent voter frustration with the country’s two (former) big-tent parties – the Christian Democrats (CDU) on the center-right (17.2 percent in Saxony-Anhalt last Sunday) and the Social Democrats (SPD) on the center-left (9.3 percent). The presence of parties on the far left (Left Party), the populist left (the Sahra Wagenknecht Alliance – BSW) and the far right (AfD) with which mainstream parties are reluctant to form coalitions. So what happens now? Stories of the Week A Lack of Leadership The answer for many people in the country, and particularly within the CDU, is clear: pin (some of) the blame on Chancellor Friedrich Merz. According to a survey taken directly after the election in Saxony-Anhalt, 88 percent of respondents agreed with the statement that if the federal government in Berlin were doing a better job, the AfD wouldn’t be as strong. And it is true that the predominant impression of the federal government ever since Merz was sworn in on May 6, 2025, is one of ineffectiveness and bickering. His rather unique combination of bumbling-plus-bravado has also not exactly endeared him to the German public. Indeed, his standing in the country is so shaky that his popularity – according to recent polls – has now dropped even below the historic lows associated with his predecessor Olaf Scholz. The situation is such that the CDU even opted to keep him largely out of the campaign ahead of the Saxony-Anhalt vote. And since then, dissatisfied rumblings within the CDU have grown louder. DER SPIEGEL’s Swantje Karich notes that the problems with the CDU go much deeper than Merz. “The center-right has a trust problem. At a press appearance following the devastating election result in Saxony-Anhalt, Friedrich Merz said that the party wanted to ‘reach people more effectively’ through ‘emotional engagement.’ It sounded as though he were announcing a political program. On the basis of that statement, it is difficult to take his empathy seriously.” “The Chancellor’s chastened appearance did, at least, reveal where he stands: with his back to the wall. Elections will be held in Mecklenburg-Western Pomerania next week, and the CDU could fare even worse there. The party is polling at between 8 and 10 percent in the state.” “What is at stake is the political tradition that has lent stability to the Federal Republic since 1945: a democratic conservatism that understands what must be preserved, but also how to embrace progress and openness to the world. If the Union continues along its current path, it risks becoming politically irrelevant after the 2029 federal election – and Germany could soon find itself with a government of the far right.” The Trumpification of Political Debate? It is often said in Germany that to understand the political and social trends that will soon be dominant in Europe, one need only look across the Atlantic to the United States. When it comes to political debate, that has certainly proven true. Donald Trump understood early on that triggering mouth-foaming outrage among Democrats is an ideal way to both generate headlines and to secure loyalty among supporters. And he realized that far more quickly than the left side of the political spectrum understood that simply ignoring the old man might be the best recipe. To be sure, there have been signs recently that the US president may be over-relying on the strategy. Earlier this week, in an apparent grandpa-discovers-AI moment, Trump sent out 60 posts in the space of 10 hours, many of them AI-assisted images portraying him as a hero – or showing Iceland as part of the US (outrageous!!!). It was also during that slew of schlock that he explicitly backed the AfD with an “MGGA” post. In Germany, though, the outrage cycle remains in full swing, with much of the focus on those who would dare to vote for the AfD. They are alternately portrayed as being dim-witted, ungrateful, backward, racist or all of the above. That, argues DER SPIEGEL columnist Sabine Rennefanz, is not particularly helpful. “Everywhere on election night, people spoke of a watershed moment, a rupture, a turning point. But what is that supposed to mean in concrete terms? A watershed would imply an interruption, a moment of pause – perhaps even a willingness to rethink and learn. At first, there was little sign of that in the main television panels. Instead, the familiar rituals that had already shaped the election campaign continued: outrage, lecturing and abuse.” “That’s just the tone, one might object. They’re only talk shows. Given that the party’s state branch has been classified by domestic intelligence officials as confirmed right-wing extremist, there are more important problems than hurt feelings on television. Yet although the condescending tone is not the cause of the AfD’s success, it is an expression of the broader mood within the so-called political center – a kind of institutional blindness that too often treats material concerns as a communications problem.” “People have a pretty good sense of whether you like them – whether you approach them with curiosity or merely study, lecture and manage them as a problem group. They notice whether you genuinely want to understand their fears and pain, or whether you are simply waiting for the chance to correct them. They can also tell whether someone still has the energy to change things, or whether they have barricaded themselves behind platitudes and empty phrases.” “Anyone who wants an egalitarian democratic society cannot promise equality only to those whose language, tastes and moral convictions they share. They must also acknowledge the wounds, resentments and fears of those whose political conclusions they consider wrong. Acknowledging them does not mean agreeing with them. But a democracy that communicates with almost half its citizens only through warnings and labels gives up on political debate before it has even begun. An atmosphere must be created in which people can express their opinions without fearing that they will be canceled. We are currently a long way from that.” East-West? One of the clear undercurrents in the election last Sunday was, of course, Germany’s ongoing east-west divide, particularly as it pertains to the success of the AfD. Historically, the party has been far stronger in the former East German states than in former West German states. The fact that this generalization no longer reliably holds is certainly one of the primary concerns that many have about the party’s growth. And yet, there is still a distinct flavor of “stupid easterners, they don’t understand democracy” to the coverage. In the weeks before the vote, there was even a rather interesting back-and-forth in Germany’s culture pages about how ungrateful eastern Germans allegedly are for being pulled out of their pre-reunification backwardness and into the light of the West. DER SPIEGEL’s Jochen-Martin Gutsch has had enough. “Ten years ago, in 2016, elections were also held in Saxony-Anhalt. The AfD won more than 20 percent, which at the time rightly provoked outrage and incomprehension in western Germany. Today, in 2026, the AfD is also polling at around 20 percent in western German states, but this no longer provokes outrage and incomprehension. Instead, it is now regarded as proof of democratic conviction and civilizational resistance. After all, in the east, it’s 40 percent!” “This allows people to continue feeling morally superior to the East, but the wiser course would be to admit: if something doesn’t happen soon, the West will turn AfD-blue too. Or bluish.” “But will anything happen? The truly depressing thing about election night was not so much the AfD leaders intoxicated by their own success. It was the representatives of the other parties, who once again said that they were utterly shocked, needed some time to digest the result and would, of course, not simply return to business as usual. The SPD, a former big-tent party, celebrated its ‘stable’ result of 9.3 percent. Congratulations!” “For 10 years, the AfD has gone from one electoral success to the next. And still, the established parties remain ‘shocked’ and scratch their heads in astonishment. How long can they keep being shocked? Friedrich Merz says he may need to communicate his reform ideas in a more ‘emotional’ way. So the CDU’s political professionals sit down together after the election, mull over a strategy, and in the end come up with this: Fritz, try to be a little more relaxed, charismatic and emotional – or something. Beyond that: no political plan, no defiance, no promise of a future. That is frightening.” What was good, what was bad for democracy? Good: Voter turnout in Saxony-Anhalt was 77.8 percent, the highest ever recorded in the state. Whatever one thinks of the result, that figure is encouraging. Democracy needs citizens to take an interest. Bad: Although a strong AfD result had been expected in Saxony-Anhalt, many politicians from the mainstream parties – including in Berlin – appeared confused, helpless and overwhelmed in their initial reactions. That is not how they will win back voters’ trust. Last Week’s Highlights: 🗳️ Meet the Germans Who Voted for the AfD: Why would voters in a country like Germany, with its Nazi past, vote for a right-wing party? It’s a question only an editor in Berlin could come up with. On the ground, the view is different. 🟦 How the AfD Wants to Expand Its Power Across Germany: The far-right AfD is planning to decimate public broadcasting in Saxony-Anhalt, revamp education and install extremists in positions of power. And it is eyeing victory on the national stage as well. 🕯️ The Continuing Reverberations of September 11: It was a generational shock, and the consequences can still be felt today - from massive surveillance and significant increases in presidential power to violent excesses at ICE. 🤝 “For Europe, Canada Is the Preferred Partner in Trans-Atlantic Relations”: In an interview with DER SPIEGEL, Canadian Finance Minister François-Philippe Champagne discusses his country’s failed trade deal with the US and why Canada is looking to Europe. 🏛️ The True Historical Roots of the AfD: During the Weimar Republic in the 1920s, there were numerous parties on the extreme right espousing “Germany first” nationalism. The Nazis may not be the best comparison for today’s AfD. 🌊 AfD in a Landslide: Merz Is the Wrong Leader for Germany: The right-wing Alternative for Germany won in a landslide in Saxony-Anhalt state elections on Sunday. What does that mean for the country at large? Thank you for your continued support and have a wonderful week! Subscribe Share Leave a comment Your SPIEGEL Substack Team Compiled and edited by Charles Hawley
Meant Health Expands Telehealth Access to FDA-Approved GLP-1 Prescriptions, Including Ozempic®
Meant Health, a digital health platform that connects patients with licensed clinicians for evaluation, prescription and ongoing care coaching, announced today that it is expanding telehealth access to FDA-approved GLP-1 medications. The move is meant to shorten the distance between someone wondering whether a treatment might be right for them and an actual conversation with a U.S.-licensed clinician who could review their history and make that call.
Missouri should make medical respite part of its health care infrastructure
Missouri’s healthcare system routinely pays for a hospital stay, a surgery or a course of treatment, then reaches the edge of its own plan when the patient has no home in which to recover. For a person experiencing homelessness, “discharge” can mean returning to a shelter, vehicle or street while managing a wound, infection, cancer […]
Posts touting mebendazole as cancer treatment go beyond the science
The anti-parasitic drug mebendazole has shown preclinical efficacy in targeting multiple cancers, but experts say social media posts calling it a "cure" go too far. Additional clinical trials in humans are necessary to prove when, at what dosage, and in which treatment combinations it could make an impact.
Posts touting mebendazole as cancer treatment go beyond the science
The anti-parasitic drug mebendazole has shown preclinical efficacy in targeting multiple cancers, but experts say social media posts calling it a "cure" go too far. Additional clinical trials in human...
Carnival of Clubs helps Business Students find Connection and Community at UA Little Rock
University of Arkansas at Little Rock School of Business students recently had a chance to connect and find their place on campus through the Carnival of Clubs, which showcases various organizations and programs — all under a festive atmosphere. With music playing, and plenty of snacks and refreshments, the Sept. 3 event brought together students, ... Carnival of Clubs helps Business Students find Connection and Community at UA Little Rock
Wilmington health tech founder launches new venture
Several years after launching his health tech startup Artemis Immersive, founder Adam Isley is setting his sights on new horizons. Co-founded in 2023 by husband-and-wife Adam Isley and Kaylan Barbrey, along with Matthew Raffa and Bill Blakesley, Artemis Immersive began as a spatial medtech company that created digital renderings of medical scans for viewing in augmented reality (AR). Isley said the firm, which won an NC Tech award in the Biotech + HealthTech Innovation category last year, has raised $1.2 million in total in seed funding since launching. Isley has since created a new venture, Research and Me, building on the Artemis platform. Like Artemis Immersive’s core software, VoxScan, Research and Me combines health data with artificial intelligence in a 3D interactive environment to help patients better understand health outcomes and provide integrative wellness support. While the Artemis product is no longer Isley’s primary focus, he said the company’s technology and ambitions have evolved into different ventures, like Research and Me. "It's a different venture building on the Artemis platform, and there'll probably be more,” Isley said. He added, "I was very disappointed in the quality of the information available to general patients about their healthcare... I wanted to give patients more and a better plate of choices." Research and Me is still in its beta phase, Isley said, with usability testing ongoing in partnership with the firm’s partner, Medicap Pharmacy and Wellness Center, owned by Barbrey. "As someone who's kind of dedicated their life to working in healthcare, I've tried to bring this spirit and passion to it,” he said, “and a lot of the resources that we'll be providing are free — like a base level of free care for any patients, or medical education if they've got specific conditions." Isley describes Research and Me as a “patient-first” platform designed to securely store and pseudonymize health data and use AI and medical literature to generate insights. The insights are presented in an interactive 3D environment for patients and providers to explore conditions, treatments and wellness plans together. "It's almost like a democratization of understanding medical information," Isley said. "We take a whole bunch of clinical data, we take a whole bunch of peer‑reviewed, published studies on PubMed, and we try to turn them into chunks of information that normal humans can understand." Like VoxScan, the Research and Me platform lets users interact with 3D anatomical models for visualization. The platform provides a space for tracking, notes and insights. The platform also supports video conferencing, Isley said, allowing providers or coaches to examine models and data together. "We wanted to create a safe environment where you can start to learn and experiment with new features about your health, using agents to do that,” Isley said. While Research and Me is in beta-phase testing with Medicap Pharmacy, Isley said he envisions the platform serving a wellness-oriented community, working with sports performance clinics and hormone optimization. Isley, who is working towards a wellness-coach board certification, also plans to offer functional wellness consults through the platform. Long‑term, Isley says he wants the platform to embody an “integrative health practitioner” approach, “connecting experts of different fields and specializations in a way that they can make a greater impact in people's lives.” “For people in the state of North Carolina, it's already a win,” Isley said of the Medicap rollout, noting that partner clinics get “immediate resources for learning about their health and wellness conditions… out of the box.” Isley plans to launch Research and Me’s provider portal in 2028 and begin pursuing integrations with larger systems, he said.
Hottest In 125,000 Years? The Staggering Science Behind The Summer Heatwave
If you felt this summer was especially brutal, the data proves you were right. According to the National Oceanic and Atmospheric Administration (NOAA), the continental United States just endured its
Hottest In 125,000 Years? The Staggering Science Behind The Summer Heatwave
If you felt this summer was especially brutal, the data proves you were right. According to the National Oceanic and Atmospheric Administration (NOAA), the continental United States just endured its
Hottest In 125,000 Years? The Staggering Science Behind The Summer Heatwave
If you felt this summer was especially brutal, the data proves you were right. According to the National Oceanic and Atmospheric Administration (NOAA), the continental United States just endured its
Hottest In 125,000 Years? The Staggering Science Behind The Summer Heatwave
If you felt this summer was especially brutal, the data proves you were right. According to the National Oceanic and Atmospheric Administration (NOAA), the continental United States just endured its
Hottest In 125,000 Years? The Staggering Science Behind The Summer Heatwave
If you felt this summer was especially brutal, the data proves you were right. According to the National Oceanic and Atmospheric Administration (NOAA), the continental United States just endured its
Hottest In 125,000 Years? The Staggering Science Behind The Summer Heatwave
If you felt this summer was especially brutal, the data proves you were right. According to the National Oceanic and Atmospheric Administration (NOAA), the continental United States just endured its
“Dark Knight” actor makes rare comment on moment he learned costar Heath Ledger died
Gary Oldman reflected on Ledger’s 2008 death, after he and the Australian actor starred in Christopher Nolan’s acclaimed “The Dark Knight” Batman movie.
Health officials see a jump in human rabies exposures and mistakes in treatments, CDC says
Rabies is a viral disease that is practically always fatal but preventable when the proper treatment is given before the patient shows symptoms.
Health officials see a jump in human rabies exposures and mistakes in treatments, CDC says
Rabies is a viral disease that is practically always fatal but preventable when the proper treatment is given before the patient shows symptoms.
Health officials see a jump in human rabies exposures and mistakes in treatments, CDC says
Rabies is a viral disease that is practically always fatal but preventable when the proper treatment is given before the patient shows symptoms.
Health officials see a jump in human rabies exposures and mistakes in treatments, CDC says
Rabies is a viral disease that is practically always fatal but preventable when the proper treatment is given before the patient shows symptoms.
Hellberg eyeing home comforts against Norwich
Middlesbrough boss Kim Hellberg is relishing a Riverside return on Saturday and wants another special atmosphere.
Cancer Is Now The Leading Health Threat For 9/11 Survivors 25 Years On
By Ellyn Vohnoutka HealthDay ReporterFRIDAY, Sept. 11, 2026 (HealthDay News) — Twenty-five years after the World Trade Center attacks, cancer has become the defining health problem among survivors who breathed the toxic dust. The number who are getting help paying for cancer treatment has roughly ...
Federal Funding Increase Brings New Resources for Tribal Health and Diabetes Programs
Federal funding for Indian health increased for fiscal year 2026, including a significant boost for a program supporting diabetes prevention and treatment in Native communities. Congress provided approximately $5.86 billion for Indian Health Service services and facilities, a 1.3% increase over fiscal year 2025. The total includes approximately $5.05 billion for health services and $809.2 […]
Boycott launched against American Diabetes Association includes journal
Trump's $500 Obamacare promise, childhood cancer treatment with long-term risks, and more health news
Chimp convalescence, ant amputation: the wild world of animal doctors
When people are sick, we seek out medications and treatments to help heal. For a long time, scientists thought that was a uniquely human ability. But it turns out, many other animals do a version of it too! And since the late 1980s, western researchers have been trying to get a peek behind the curtain. And aside from just cataloguing all the cool examples just to know, there’s a real hope that studying animals’ medical cabinets may be the most promising way to expand our own. We get into the weeds with freelance science journalist Mandy Nguyen.Interested in more animal stories? Email us your ideas and questions to explore at shortwave@npr.org. They may become a future episode!Support public media with NPR+ and enjoy perks for over 25 podcasts like this one. This show’s perks include sponsor-free listening. Learn more at plus.npr.org.
Inside the Republican Midterm Convention, Where It Was ‘Trump-a-Palooza’
Amid the glitz, glamour and party atmosphere of an unusual midterm convention in Dallas, the president boasted of his accomplishments, predicted Republican victories and all but ignored the daunting political landscape his party faces this fall.
Airplane Turbulence May Worsen Thanks to Trump
Pilots depend on climate data from the National Center for Atmospheric Research to fly. The government wants to dismantle it.
Rensch: ‘Roma must be ready for Fenerbahce strong start’
Devyne Rensch warns Roma ‘must be ready’ for the atmosphere put on by Fenerbahce fans in tonight’s Champions League opener.It kicks off at the Sukru Saracoglu Stadium in Istanbul at 17.45 UK tim...
Lee Health convenient care centers offer shorter wait times for minor injuries
Lee Health's convenient care centers provide walk-in service and same-day treatment for minor injuries, offering an alternative to hospital visits.
September brings new name for PCOS
Polycystic ovary syndrome has been renamed polyendocrine metabolic ovarian syndrome to emphasize metabolic health and improve diagnosis and treatment.
Take Charge of Your Health Today: Safe and affordable housing
JENNIFER THOMPKINS Alzheimer’s disease and other forms of dementia can affect any family, but access to diagnosis, treatment and support is not equal across communities. For many African Americans, the path to care is complicated by limited access to health services, transportation, healthy food, reliable information, and trusted organizations. Those barriers, according to Jennifer Thompkins, president of […]
Luminis Health cyberattack delays cancer treatment and test results
The cybersecurity attack affecting Anne Arundel Medical Center and Luminis Health Care remains unsolved almost a week after it was first reported the hospital system was under a Code Black.
OPINION: A mental health crisis should end in treatment, not death
The death of Jayden Stephenson shows what can happen when Ohio's civil commitment process isn't used as intended.
Autism Decoded: New Science Is Opening Paths to Better Treatments
In the past few decades, researchers have identified hundreds of genes that increase the risk of autism spectrum
Independent Atmore trucker says higher diesel costs putting strain on business
PENSACOLA, Fla. -- Record-high diesel prices are putting a squeeze on independent truck drivers.
Does AFC Bournemouth’s Atmosphere "Problem" Raise a Bigger Question?
Despite the emphatic 4-0 win, Bournemouth’s underwhelming atmosphere against Lincoln was tangible, and as The Price of Football recently explored, the Cherries’ growing hospitality offering highlights a wider debate about matchday revenue, premium seating and what makes a stadium truly "valuable".
Luminis Health cyberattack delays cancer treatment and test results
The health system said it is still trying to determine which systems and how many patients are affected across its entire organization.
Scientists Made Ice Stay Solid Above 2,000°C. The 'Superionic Ice' Could Be Found Inside Uranus and Neptune
The researchers squeezed water to millions of atmospheres and discovered a bizarre new form of ice.
Healthy Living with USA Health: Enlarged Prostate Treatment Options
In this Healthy Living, we talk with Troy M. Sofinowski, M.D., an Endourologist at USA Health.
Veterans' mental health challenges
For many veterans, coming home does not mean leaving the impact of military service behind. As we approach the 25th anniversary of 9/11, it is important to recognize the mental health struggles many veterans face—often without treatment. Rawle Andrews jr., executive director of the American Psychiatric Association Foundation, discusses this with Good Day Austin.
Prisma Health to host free webinar on menopause
Prisma Health is offering a free webinar on Sept. 23 to help women better understand menopause, recognize common symptoms, and explore treatment options that can improve their quality of life.
Adidas' Handball Spezial Gets a Dynamic Polka Dot Collab
Sneaker Politics and Adidas have teamed up on a brilliant Handball Spezial featuring a patchwork polka dot treatment inspired by Buddy Guy. Find out how to buy the sneaker here.
Lava-Covered Planets Are Defying a Key Rule of Planetary Science
Researchers developed a model showing how lava-covered planets close to their stars can hold onto their atmospheres, which could help guide the search for life beyond our solar system. Some planets orbit so close to their stars that intense radiation should strip away their atmospheres. Yet several of these scorching, lava-covered worlds still retain thick
Labor Department Mental Health Insurance Guidance Seeks Balance
The Department of Labor released new guidance seeking to narrow enforcement related to gaps in how employers cover treatments for mental health and substance use disorders.
ECMO saves newborn with severe lung damage after RSV scare
At just 2 weeks old, Jocelyn Selle was flown to Sanford Children's Hospital in Sioux Falls -- the only home for ECMO treatment in the Dakotas.
Meet a Health Hero Finalist: Sharon Pervez-Khan
After her daughter Elora was diagnosed with an incurable, cancerous brain tumor, the Villanova mom made it her mission to accelerate research, funding, and life-saving treatment.
Scientists find a bone-building switch that could fight osteoporosis
An experimental compound called AP503 significantly strengthened bones in mice by activating GPR133, a receptor that boosts bone formation while slowing bone loss. Because the same treatment has also been linked to stronger muscles, researchers see intriguing potential for combating age-related decline and osteoporosis.
New Eugene facility will expand Oregon’s residential behavioral health system for youth
A 12-bed secure inpatient treatment facility in Eugene will serve youth ages 10-17 with acute behavioral health needs.
Epic v. Health Gorilla: “Working as Designed”
We’ve been on a bit of a legal bender since just before Labor Day, so let’s keep a good thing going! As predicted, Epic does not want its case against Health Gorilla consolidated with the data breach cases, so it filed a motion to vacate the conditional transfer. And because they had to explain to the Panel why this case is different, they put a good chunk of previously unseen Epic v. Health Gorilla discovery record on the public docket! Roll the tape! The Case Against Consolidation Before we get to the fun stuff, let’s do the housekeeping. Epic's motion boils down to three arguments (sorted in ascending order of how well they land): A judge has already decided this. Judge Olguin declined to relate the fraud action to another ELU case (Patterson v. UVA Health), holding that the two do not call for determination of substantially similar questions of law or fact. Epic asks the Panel to treat that (a Rule 42 ruling) as law of the case. The overlap is thin. The three common questions Health Gorilla and the Panel identified are neither numerous nor complex (the qualities the Panel looks for before centralizing). Moreover, they are outnumbered by the questions unique to each side: The breach cases turn on security architecture, notification timing, and patient-level access. The fraud action turns on false treatment attestations and breaches of the framework agreements. Consolidation costs more than it saves. 17 of 21 parties in the fraud action do not appear in a breach case. The cases are also at very different stages: Olguin has a scheduling order running through a January 2028 trial while the breach actions are much more nascent. I like the last two more than the first because they attack the basic economics of an MDL: there just may not be enough shared discovery here to justify dragging all the defendants and a relatively mature fraud case all the way to Florida. On the other hand (while I know exceedingly little about MDL and Rule 42), I have a hard time seeing why a district judge's decision about his own docket would control what the Panel does with the separate § 1407 question. I might be reading between the lines too much, but I sorta think Epic's own brief half-concedes this, framing the two provisions as "two sides of the same coin" but then adding "respectfully submit" (which is often lawyer speak for “we know this is a reach”). The Ladder Gets More Rungs Anyway, the arguments are not why you're here (aside from the lawyers, maybe). Back in June, we discussed how Epic was using the smaller defendants to build an evidentiary ladder toward Health Gorilla and Unit 387. Turns out discovery has been adding a few rungs of its own.
New outpatient clinic focused on suicide prevention opens in Burlington
University of Vermont Health held an open house last week to celebrate the opening of the Asha Clinic, which it describes as the only program in the region focused exclusively on suicide care. The clinic's work is led by Craig Bryan, an expert in suicide treatment and research.
Can AI fix health care? In the chaos of emergency rooms, the technology comes up short
CEOs of the biggest AI companies have predicted the technology will “eliminate most cancer” and “improve treatment of most other ailments.” But nowhere better illustrates the challenge facing AI than an emergency department.
Why does early treatment matter for psychotic episodes?
Early treatment for psychosis can improve recovery and challenge the idea that mental illness means a lifetime of suffering.
Anak Krakatau Rumbles Again
A powerful eruption from the Indonesian volcano lofted ash into the atmosphere, disrupting thousands of flights and degrading air quality.
Bernalillo County DA highlights need for accountability and reform in juvenile crime and behavioral health
Bernalillo County District Attorney Sam Bregman addressed crime, juvenile reform and behavioral health during a speech in Albuquerque, emphasizing the importance of accountability and treatment working together.
Scientists engineer ready-to-use cancer-fighting T cells for solid tumors
T-cell receptor, or TCR, therapy is a cancer treatment that genetically reprograms immune cells, called T cells, to hunt down cancer with precision. It's similar to another treatment, CAR T-cell therapy, ...
Joe Biden shares health update after prostate cancer diagnosis while issuing warning to others
Joe Biden revealed his radiation treatment from last fall "worked as intended" as he urged men to discuss prostate cancer screening with their doctors.
The Villages Health’s $541 million settlement highlights the cost of ‘upcoding’
The settlement describes how The Villages Health would go back into patients' medical files months later and add diagnoses -- sometimes adding in monitoring, evaluations or treatments.
Santa Cruz to build a new type of mental health care center for youth
Serenity Smith, who lived at a residential treatment facility in Santa Cruz in 2024, drives to work in Aptos on Monday, Aug. 31. (Amaya Edwards — Santa Cruz Local/CatchLight Local) Located at: 5300 Soquel Ave., Santa Cruz, CA 95062. Call (831)540-4141. Behavioral Health Resources
Parents of San Diego mosque gunman say a mental health facility failed to heed FBI warning
LOS ANGELES (AP) — The mother of Caleb Vazquez alleges in her lawsuit that Park Mental Health Treatment of San Diego failed to intervene despite signs that her 18-year-old son posed an imminent threat to himself and others.
Youth with CF on approved treatment still face mental health issues
Youth with cystic fibrosis continue to experience mental and behavioral health concerns despite treatment with Trikafta, according to a study.
Scientists Discover the 7 Stages a Meteoroid Goes Through Before Hitting Earth
An analysis of 75 meteorite falls identified seven distinct processes that occur as space rocks melt, break apart, and slow down before reaching the ground. A space rock entering Earth’s atmosphere does far more than simply “burn up.” By examining 75 meteorite falls recorded in videos and photographs, researchers identified seven distinct stages that shape
AZ's R&D chief Barr touts internal 'science success story' after IL-33 antibody's stellar showing in COPD
With a detailed data drop that AstraZeneca’s R&D chief described as an internal “science success story,” the British Big Pharma has secured an FDA priority review for what it believes could become a flagship biologic in chronic obstructive pulmonary disease (COPD). In detailed results from the late-stage Oberon and Titania trials—first teased in March and detailed in full at the European Respiratory Society Congress in Barcelona this week—the drugmaker laid out the extent of its IL-33 inhibitor’s potential to reduce moderate and severe exacerbations in a wide range of COPD patients still struggling with those “lung attacks,” as AstraZeneca’s Sharon Barr, Ph.D., called them, despite using standard-care inhaled therapy. In the headline results, a 300 mg dose of tozorakimab given once every four weeks curbed those moderate and severe exacerbations in the studies’ primary population of former smokers by 29% in the Oberon study and 34% in Titania. In the overall population of both current and former smokers, these reductions were 30% and 29%, respectively, versus placebo and inhaled standard of care. The benefits also extended to clinically meaningful exacerbation reductions in all prespecified patient subgroups and specifically turned up promising signals in patients across a range of blood eosinophil counts, with Barr telling Fierce that “it’s the details that make this even more exciting than the high-level results that we’ve already shared.” In fact, during AZ’s tozorakimab poster presentation at the ERS 2026 Congress this past weekend, attendees were so enamored by the data that event organizers had to encourage people to clear the room and look at the other presentations on offer, Barr said in an interview. “I think it really speaks to the fact that there is a lot of buzz around these data because the entire respiratory community has been so desperate for new therapies for these patients,” she explained. The respiratory disease continues to represent a “staggering unmet medical need,” Barr said, highlighting the COPD exacerbations that the Oberon and Titania studies homed in on, which she added carry a greater mortality risk than a heart attack. “When a patient has a severe exacerbation, only about half of them are still alive within three and a half years,” she pointed out. As for tozorakimab specifically, Barr christened the molecule “an AstraZeneca science success story,” harkening several years back to the point at which researchers began to explore IL-33 as a driver of respiratory disease, and COPD in particular. At the same time, “there was still so much that wasn’t understood,” she admitted, highlighting the insight that IL-33 signals through both ST2 and EGFR through the RAGE pathway, a discovery Barr attributed to AstraZeneca's own scientists. Understanding the need to tackle both pathways in COPD—and aware of competitor candidates in the hopper, including one that bound ST2—the company ultimately had to make some “courageous decisions,” Barr said. These included taking a prior COPD molecule offline and going back to the drawing board to reinvent its potential IL-33 label “to make sure that we had a molecule that could block signaling through both arms of the pathway, through both the reduced form and the oxidized form, knowing that we wouldn’t be first, but striving to be best.” “When we put [tozorakimab] into the clinic, we firmly believed that we had a differentiated molecule, and we saw the other molecules blocking just ST2 or partially blocking IL-33, unable to deliver two positive pivotal studies in COPD,” Barr explained. “We kept marching forward because we believed our molecule was differentiated, and now I think we have the clinical validation that supports that.” Ultimately, AstraZeneca finds itself on much better footing these days when it comes to potential biologic rivals to tozorakimab in COPD. Sanofi and Regeneron’s Dupixent, for instance, is approved to treat COPD exacerbations in patients with high eosinophil counts, but not low ones. Meanwhile, the future has become cloudier for other next-gen IL-33 candidates from Sanofi and Regeneron, as well as Roche, which have suffered trial flops in recent years. One other potential ingredient for AstraZeneca’s success in its duo of studies was that the company was “ambitious in the trial design, willing to look at an all-comers population,” Barr said, “and willing to enroll the most severe patients.” Prior studies for would-be biologics rivals in COPD “avoided enrolling” those patients, she pointed out. She also highlighted the Big Pharma’s painstaking design of exacerbations in its trial, which “gave us a very rigorous readout,” and pointed to “the extra effort and investment” the company put in to understand the effect of mucus plugs in patients. Barr described mucus production as a “key feature in disease diversity,” noting that mucus plugs—obstructing clumps of mucus that block patients’ airways—are associated with worse outcomes in COPD. In its data announcement, AstraZeneca noted that an integrated analysis of Oberon and Titania found tozorakimab “demonstrated a reduction in patients’ mucus plug score,” with the pharma claiming its biologic is the first to deliver such results in a broad COPD population. “So being able to reduce those mucus plugs, we expect, is an important part of driving benefit for patients who are living with COPD,” Barr said. Again touching on the breadth of the study populations, Barr added that tozorakimab “worked across all eosinophil levels in both current and former smokers across all levels of lung function,” which she suggested “really simplifies decision-making for clinicians, and it allows them to offer therapy to the broadest possible patient population.” In the highest patient eosinophil count group, tozorakimab helped chart a 43% reduction in exacerbation risk, which Barr stressed were “unprecedented data.” In the mid-level group, AZ’s drug delivered a 23% reduction and, in the lowest group, a 34% reduction in eosinophils, which Barr said suggests efficacy “in all patient subgroups.” As for AZ’s recent guidance upgrade on the medicine’s sales opportunity, the lift from a $3 billion to $5 billion range to $5 billion plus was informed by multiple factors, Barr said, including the fact that “in 2024, there were multiple competitors, and there aren’t anymore.” Additionally, “we know that this is a massive unmet medical need, and this is a really incredible set of data that we think will be very convincing to the clinical community,” Barr said. Looking ahead to a potential evolution of the COPD treatment landscape, Barr noted that most patients start treatment in the community with an option like a triple therapy, and for them, having an option like AstraZeneca’s inhaler Breztri will remain a “really important part” of that journey. But of the patients uncontrolled on triple therapy, which Barr described as “about half of them today,” just a “small fraction” are currently eligible for biologic therapy, which she emphasized AstraZeneca is working to change. Understanding that COPD is not a “one-size-fits-all” disease, AstraZeneca is also looking at its antibody drug Tezspire for patients with T2-driven disease, and the company continues to think about new mechanisms for tackling COPD through both systemic and inhaled drugs, Barr said.
Sinclair's Criminally Obsessed to Present "Maternal Mental Health: How the Lindsay Clancy Trial Could Change Treatment" National Town Hall to Air on September 9
BALTIMORE – September 8, 2026 – Sinclair today announced a national town hall examining maternal mental health and the questions surrounding diagnosis, treatment and intervention that have been brought into focus by the Lindsay Clancy trial. Maternal Mental Health: How the Lindsay Clancy Trial Could Change Treatment will stream September 9 across Sinclair’s television station...
Scientists discover a powerful new antivenom hidden in rattlesnake blood
Researchers discovered that combinations of toxin-blocking proteins naturally found in rattlesnake blood can powerfully neutralize venom from several dangerous snake species. In lab tests, the mixtures were about 10 times more potent than a current commercial antivenom, pointing toward a new generation of nature-inspired snakebite treatments.
An administrative gap delays access to new pancreatic cancer treatment
A new wave of illegal fruity vapes, more and more kids on GLP-1s, and other health news from Morning Rounds
List of DVD release dates for Sept. 8 and beyond
Following is a partial schedule of coming movies on DVD. Release dates are subject to change: SEPTEMBER 8: Minions & Monsters 8: Supergirl 8: Passenger 8: Leviticus 8: Batman: Knightfall
Maine cancer survivor sharing wellness, health lessons in new app
Tom McGowan of Windham is using what he learned during treatment to help better the lives of people around the world.
Americans aren't divided on health care. Washington is.
Drug pricing. Medicaid. Medicare. The ACA. Substance use treatment. On every one of these fronts, bipartisan majorities want government to do more.
2,300 Roma fans expected for first Champions League match
The atmosphere in Istanbul will be heated. It won’t be an easy trip for Roma, but Gian Piero Gasperini’s team seems ready to face Fenerbahce among their fans, coming off a 2-1 defeat to Besiktas. ...
X-Men Reboot’s Wild 4-Movie Comparison Includes Batman V Superman
A leaked script review for Marvel Studios’ X-Men reboot draws comparisons to four wildly different films. The surprising mashup description hints at the tone and style audiences can expect from the MC...
Former “RHOBH” star Brandi Glanville details 18-hour IV treatments: ‘I feel like death’
“I know everyone wants to know exactly what I’m dealing with. I’m not ready to share that part just yet,” the “Real Housewives of Beverly Hills” alum wrote.
New Super Smash Bros and Nintendogs games are on the way, according to prominent Nintendo leaker
A prominent Nintendo leaker has spilled more information about the Switch 2's upcoming games, which include a Nintendogs comeback and a new Super Smash Bros.
Why Syracuse Football's Improved Game Day Experience Is a Success
The University implemented changes to the Saturday afternoon atmosphere on campus.
Perspective | The biggest barrier to teen mental health isn’t treatment
Explore this perspective on Alliance Health's innovative school-based partnership model for supporting student mental health.
The science behind the beauty business
Some of Europe’s industrial champions may be in retreat, but its cosmetics sector remains a global leader, buoyed by healthy demand, recognised brands and a reputation for innovation."The fact is, the science in cosmetics is better here in Europe than anywhere else in the world,” says Pierre Morvan, CEO of Technature, a private label cosmetics manufacturer located near Brest in France’s northwestern Brittany region. “You have to have good science in order to make the difference, and that is why we invest so much in research and innovation.”Across Europe, the beauty and skincare products sector supports an estimated 3.6 million jobs, including 265,000 employed directly in the industry, according to the Cosmetics Europe trade group.. Cosmetics production contributes an estimated €11 billion to the EU economy, and generated €30 billion in export revenue last year, a €400 million rise from 2024.Technature itself has a global footprint, supplying products for 1,500 brands in 65 countries. Its range of skin gels, facial masks, nail treatments and other products include natural ingredients and extracts derived from plants, such as seaweed, that are developed and refined through science-based analysis and testing.While industry projections point to sustained growth for the foreseeable future, driven by emerging economies and wider availability of exclusive brands that were once chiefly sold by high street retailers, the sector is not immune to the impact of geopolitics and trade wars. The Trump Administration’s tariff threats have dented cosmetics exports to the EU industry's largest overseas market. After the European Parliament approved the EU-US Turnberry Agreement in June, setting a 15% levy on many EU goods, the French Federation of Beauty Companies warned that “exports are falling sharply” and urged the EU to negotiate an opt-out for cosmetics.Technature’s CEO flags South Korea as an emerging competitor, partly due to its assertive marketing efforts. “I would have to say I am a little bit scared,” Morvan says, regarding the growth potential of the South Korean cosmetics industry. “This is why science and innovation are so important if Europe is to remain the leader.”With a workforce of 200, including biologists, chemists and other scientists, around 15% of Technature’s staff work in three research and development (R&D) labs. A similar number work in four quality control and assurance facilities, where science plays a crucial in ensuring product safety in a sector that is subject to the European Cosmetics Regulation.Educational exchange between industry and academiaIn recognition of Technature’s research and innovation, Morvan was selected as one of Brest’s ambassadors to Science Comes to Town (SCTT), a European initiative to strengthen communications and understanding between science and society. Brest is one of three coastal cities in the EU-funded programme, alongside Split (in Croatia) and Kiel (in Germany). From 7-11 September, Brest will host the EU TalentOn contest featuring 100 early-career researchers from across Europe.Morvan appreciates the value of engagement with educational and scientific institutions as well as the home community. For instance, Technature collaborates closely with university partners to enhance its in-house R&D. In addition, it invites students to its labs and sends its own researchers to local institutions. "We absolutely want the students to know what the industry is all about,” Morvan says, noting that seeing science in action can help young people “understand that they can do something real with science, to create something with what they are learning.” He says another important benefit: encouraging new generations of young people to consider a career in cosmetics.Community involvement also raises awareness about Technature and the skincare industry as a whole. “The public gains recognition of the innovative company that we are, and this is important for getting new customers,” Morvan says. One of its recent innovations — tiny, colourful cosmetic pearls that release skin moisturisers on application — was showcased at this year’s VivaTech event in Paris.Morvan holds a master's degree from the Brest Business School and studied animal production and biology in Brest at the University of Western Brittany (UBO), an SCTT partner, and at the University of Tours. He got his start in business in 2002, initially working on using seaweed as a raw material in the food industry before transitioning to cosmetics. Morvan has always been interested in connecting science and business, reflecting one the goals of SCTT to enhance public-private collaboration.The invitation to participate in SCTT was unexpected. “It was a surprise to get a call from the city of Brest saying that they wanted me on this programme,” Morvan recalls, adding that officials were drawn by his company’s R&D. “It's not only theory and science fundamentals. Our science is something that is applicable to the global market — and important for the community.”Science|Business, which connects policymakers, academics and industry through its news reporting, analysis and events, is an SCTT partner.
Verisk: One atmosphere, one framework – how science and AI connect views of global risk
A single-system approach to catastrophe modelling is required to capture the interconnected atmospheric drivers that shape risk across regions and perils, argues Verisk’s Jay Guin.
Mark Walter and Magic Johnson’s Dodgers deal gets the Pablo Torre treatment
The sports investigative journalist examines Mark Walter’s Dodgers purchase, tracing financial ties involving Magic Johnson.
In 1996, Columbia scientists shifted Biosphere 2’s 2.6-million-gallon Arizona ocean between ice age, modern and future CO₂ every 3 months; future chemistry cut coral calcification by about 40%
For years, scientists argued about whether it would be safe for the ocean to absorb the carbon dioxide that people release into the atmosphere. When Biosphere 2 began, it was a widely reported experiment in which people lived in confinement to test whether a closed biosphere could support them.
Antarctica gained a record 695 billion tons of ice. Scientists found the surprising reason
East Antarctica gained an astonishing 695 billion tons of ice between 2021 and 2023, temporarily slowing Antarctica’s long-term decline. Researchers found that warming thousands of miles away in the tropical ocean altered atmospheric circulation and funneled moisture toward the continent, triggering exceptionally heavy snowfall.
Scientists find breast cancer cells hiding behind protective “shields”
Researchers have mapped breast tumors in striking detail and uncovered hidden pockets of dormant cancer cells that may help explain why cancer can return after treatment. Unlike rapidly dividing cells, these quiet cells can essentially hibernate, allowing them to evade chemotherapy and reactivate later. The team found that they are often surrounded by immune cells and connective tissue cells that may act like a protective shield.
Scientists altered the air around a Wisconsin forest for 11 years; extra CO₂ drove 39% more productivity, but ozone reversed part of the gain
What happens when young forest communities spend more than a decade growing in air with unusually high levels of carbon dioxide and ozone? Scientists in Wisconsin set out to find the answer by changing the atmosphere around these communities and tracking how the trees responded over 11 years.
Parents of San Diego mosque gunman say a mental health facility failed to heed FBI warning
The parents of Caleb Vazquez are suing Park Mental Health Treatment of San Diego, claiming it did not act on FBI warnings about their son’s online activities relating to school shootings. The facility disputes responsibility for the teenager’s actions.
Scientists find a weak spot in one of the deadliest brain cancers
Researchers may have found a new way to weaken glioblastoma’s defenses against treatment. Blocking a protein called SET prevented tumors from forming in preclinical models, while targeting related proteins made cancer cells more vulnerable to radiation. The strategy works by restoring activity of PP2A, an enzyme that glioblastoma cells appear to suppress. Human testing will be needed to determine whether the approach is safe and effective.
Sonos Arc Ultra Dolby Atmos Soundbar Drops Back to a Record Low With Hundreds Off for Labor Day
The 9.1.4 surround sound Arc Ultra overperforms its new $899 price tag with voice control and Dolby Atmos.
Health officials warn public to avoid Shiawassee River after sewage overflow
Nearly 2 inches of rain fell within two hours, overwhelming the city's wastewater treatment plant Thursday.
ADHD UK Cannot Hide the Flawed Science Behind the Diagnosis and Its Treatment
The extensive critique of the biomedical account of ADHD and its treatment with stimulant medication has persisted for decades.
Cascadia Health opens 10-bed secure mental health treatment facility in Southeast Portland
A new secure residential treatment facility in Southeast Portland is now open, adding 10 beds for adults with serious mental illness as Oregon continues expandi
Israeli scientists find ‘multitasking’ gene controls mood and metabolism in mice
Weizmann Institute researchers find Orthopedia gene plays critical role throughout life after aiding in-utero brain development; study may help treatment of anxiety and metabolic disorders
Puerto Rico water crisis, youth marketing campaign: CT politics news
Plus: CT commemorates International Overdose Remembrance Day, new cancer treatment arrives, and officials highlight local Latino businesses.
Plain Language as Scientific Accountability: How to Communicate Science Beyond Academic Audiences
This joint UW/Fred Hutch—Penn CFAR session brings the two CFARs together in conversation around how we communicate science beyond academic audiences. This session will present examples of technical language from HIV cure, prevention, and treatment research and ask what happens when the people most affected by the science cannot easily understand what researchers are saying. […]
Armor Health and the Stark County Sheriff's Office Partner in Launching PATH Program at Stark County Jail and Celebrate First Graduates
/PRNewswire/ -- Armor Health (ArmorHealthcare.com), a national provider of correctional healthcare, has launched the Prevention, Accountability, Treatment &...
At least 5 other states join Mass. in covering transgender kids’ health care under Medicaid
The states, including half of New England, vow to cover the care after a new rule from the Trump administration will cut off federal funding for many treatments starting in October.
Brentford reiterates commitment to ensuring acceptable behaviour
Brentford supporters create a fantastic atmosphere at Gtech Community Stadium on every matchday.Season after season, both home and away, our fans provide incredible support to our men’s, women’s a...
Prostate Health: Latest Treatments, Screening Guidelines, More
September is prostate cancer awareness month, so board-certified surgeon Dr. Cedrek McFadden stops by TODAY to share the latest in prostate cancer treatments. He talks about different types of diagnosis, how family genetics come into play, when to get screened, and more.
Motorcycle wreck in Chase County sends Topeka man to Newman Regional Health for treatment
A Topeka man suffered possibly serious injuries when his motorcycle crashed in southern Chase County early Thu...
Patient preference science is changing how we define a better treatment
As we enjoy the last days of Summer and head into September, one of the clearest shifts we are seeing across life sciences is a surge in demand for patient preference science. Some of that momentum reflects the work of Kielo Health, Sanius Health’s preference science division, led by Dr Tommi Tervonen, Chief Scientist. The question behind the science is simple but increasingly important: when treatment choices involve trade-offs, what do patients actually value most today?
‘Distressing’: East Texas Residents Struggle to Find Mental Health Services
Survey finds costs, access and timely treatment are putting people at risk.
Iron helped scientists trace Earth's oxygen. Now it's telling a bigger story
For decades, scientists have studied iron preserved in ancient rocks to reconstruct how Earth's oceans and atmosphere became rich in oxygen. A new study suggests iron has recorded other major transformations ...
Hubble spots a mysterious 10-sided 'decagon' growing around Saturn's south pole
The Hubble Space Telescope spied a large atmospheric phenomenon on Saturn: a decagon surrounding the south pole.
Antarctic expedition reveals why Southern Ocean clouds remain one of climate science's greatest challenges
The Southern Ocean plays a pivotal role in regulating Earth's climate, yet the clouds that blanket this remote region remain among the least understood features in atmospheric science. By controlling ...
Scientists revive coral dying from heat using live bacteria
Researchers successfully applied probiotic and postbiotic treatments for the first time in open sea to save the marine life form. The post Scientists revive coral dying from heat using live bacteria a...
In the shadow of Clancy case, U.K. treatment of postpartum psychosis wins supporters
Britain’s trailblazing maternal mental healthcare program gains attention as the serious psychological condition comes under greater scrutiny.